- Home
- EEA vs BTMD Comparison
EEA vs BTMD Comparison
Compare EEA & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EEA | BTMD |
|---|---|---|
| Founded | 1986 | 2012 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 80.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EEA | BTMD |
|---|---|---|
| Price | $10.56 | $2.47 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 9.2K | ★ 148.1K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | $3.14 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $7.45 | $2.32 |
| 52 Week High | $9.26 | $6.12 |
Technical Indicators
Market Signals| Indicator | EEA | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.32 | 41.45 |
| Support Level | $10.09 | $2.39 |
| Resistance Level | $10.83 | $2.58 |
| Average True Range (ATR) | 0.37 | 0.13 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 36.71 | 20.43 |
Price Performance
Historical ComparisonAbout EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.